Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study protocol: targeted delivery of interleukin-12 in combination with hepatic artery infusion pump therapy for patients with adrenocortical carcinoma liver metastases.

BMC cancer·2026
Same author

Exploring neutral backbones in phosphorodiamidate morpholino oligomers: synthesis and biophysical properties.

Chemical communications (Cambridge, England)·2026
Same author

Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer.

Cell reports·2026
Same author

Non-enzymatic RNA Glycation is a Metabolic Sensor of Cellular Stress.

bioRxiv : the preprint server for biology·2026
Same author

Protection of SARS-CoV-2 Infection by Targeting Viral Spike Protein With De Novo Designed ACE2-Derived Undecapeptide.

Journal of peptide science : an official publication of the European Peptide Society·2026
Same author

Antibody Blockade of Ly49/MHC-I interactions enhances Innate and Adaptive Immunity Against Cancer Metastasis.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 17, 2026

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method
16:07

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method

Published on: September 16, 2017

Tumor Necrosis Factor alpha (TNFalpha) regulates CD40 expression through SMAR1 phosphorylation.

Kamini Singh1, Surajit Sinha, Sunil Kumar Malonia

  • 1National Centre for Cell Science, Pune University Campus, Ganeshkhind, Pune 411 007, Maharashtra, India.

Biochemical and Biophysical Research Communications
|December 17, 2009
PubMed
Summary

SMAR1 normally represses CD40 gene transcription. TNFalpha triggers SMAR1 and STAT1 phosphorylation, releasing CD40 repression and activating its expression during inflammation and tumorigenesis.

More Related Videos

Detection of CD40 Protein-Umbelliferone Interaction via Differential Scanning Fluorescence
05:30

Detection of CD40 Protein-Umbelliferone Interaction via Differential Scanning Fluorescence

Published on: March 1, 2024

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Related Experiment Videos

Last Updated: Jun 17, 2026

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method
16:07

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody (mAb) by Neutralizing TNF Using an In Vitro Bioanalytical Method

Published on: September 16, 2017

Detection of CD40 Protein-Umbelliferone Interaction via Differential Scanning Fluorescence
05:30

Detection of CD40 Protein-Umbelliferone Interaction via Differential Scanning Fluorescence

Published on: March 1, 2024

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Area of Science:

  • Immunology
  • Molecular Biology
  • Gene Regulation

Background:

  • CD40 is crucial for inflammatory responses and tumorigenesis, often regulated by the JAK/STAT pathway.
  • Tumor necrosis factor-alpha (TNFalpha) is a key cytokine in inflammation and cancer, known to activate CD40.
  • SMAR1 has previously been shown to repress Cyclin D1 transcription via a HDAC1-dependent complex.

Purpose of the Study:

  • To investigate the role of SMAR1 in regulating the transcription of the NF-kappaB target gene, CD40.
  • To elucidate the molecular mechanisms underlying TNFalpha-mediated CD40 expression.

Main Methods:

  • Chromatin immunoprecipitation (ChIP) assays to analyze protein-DNA interactions.
  • Western blotting to detect protein phosphorylation and translocation.
  • Reporter assays to assess gene promoter activity.

Main Results:

  • SMAR1 recruits HDAC1 to the CD40 promoter, forming a repressor complex that suppresses basal transcription.
  • TNFalpha stimulation induces SMAR1 phosphorylation at Ser-347, leading to its cytoplasmic translocation and release of repression.
  • Concurrently, TNFalpha triggers JAK1-mediated phosphorylation of STAT1 at Tyr-701, promoting its nuclear translocation and CD40 activation via p300 recruitment and histone acetylation.

Conclusions:

  • TNFalpha regulates CD40 expression through a dual phosphorylation mechanism involving both SMAR1 and STAT1.
  • This study reveals a novel regulatory pathway for CD40, impacting inflammatory and tumorigenic processes.